|
Video: What is a Stock Split?
|
|
Adynxx is a technologies company that commercializes differentiated regenerative medical products which assist the body in the repair of human tissue. Co.'s subsidiary, Celleration, Inc. developed the MIST® Ultrasound Healing Therapy (MIST Therapy) therapeutic ultrasound platform for the treatment of acute and chronic wounds. MIST Therapy is a noncontact, low-frequency ultrasound delivered through a saline mist to the wound bed. Co. has a license in intellectual property related to certain placental based products for wound care and wound management, including those made from extracellular matrix derived from the human placenta, and Biovance® Amniotic Membrane Allograft. According to our ADYX split history records, ADYX has had 1 split. | |
|
ADYX (ADYX) has 1 split in our ADYX split history database. The split for ADYX took place on May 06, 2019. This was a 1 for 6 reverse split, meaning for each 6 shares of ADYX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split.
When a company such as ADYX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ADYX split history from start to finish, an original position size of 1000 shares would have turned into 166.666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ADYX shares, starting with a $10,000 purchase of ADYX, presented on a split-history-adjusted basis factoring in the complete ADYX split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
12/17/2021 |
|
Start price/share: |
$47.40 |
|
End price/share: |
$0.01 |
|
Starting shares: |
210.97 |
|
Ending shares: |
360.14 |
|
Dividends reinvested/share: |
$6.30 |
|
Total return: |
-99.96% |
|
Average Annual Total Return: |
-64.51% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3.60 |
|
Years: |
7.65 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
12/17/2021 |
|
Start price/share: |
$47.40 |
|
End price/share: |
$0.01 |
|
Dividends collected/share: |
$6.30 |
|
Total return: |
-86.69% |
|
Average Annual Total Return: |
-23.16% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,331.05 |
|
Years: |
7.65 |
|
|
|
Date |
Ratio |
05/06/2019 | 1 for 6 |
|
|